Works matching DE "ERIBULIN"

Results: 280
    1

    HT1080 Human Fibrosarcoma Cells Selected for Super-eribulin Resistance In Vitro Become More Malignant and Are Arrested Synergistically by Methionine Restriction in Combination With Eribulin in Nude Mice.

    Published in:
    In Vivo, 2025, v. 39, n. 3, p. 1275, doi. 10.21873/invivo.13931
    By:
    • SEI MORINAGA;
    • KOHEI MIZUTA;
    • BYUNG MO KANG;
    • QINGHONG HAN;
    • BOUVET, MICHAEL;
    • NORIO YAMAMOTO;
    • KATSUHIRO HAYASHI;
    • HIROAKI KIMURA;
    • SHINJI MIWA;
    • KENTARO IGARASHI;
    • TAKASHI HIGUCHI;
    • HIROYUKI TSUCHIYA;
    • SATORU DEMURA;
    • HOFFMAN, ROBERT M.
    Publication type:
    Article
    2
    3

    Pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor in previously treated mantle cell lymphoma: updated results from the phase 1/2 BRUIN study.

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
    By:
    • Jurczak, Wojciech;
    • Wang, Michael;
    • Shah, Nirav;
    • Alencar, Alvaro;
    • Gerson, James;
    • Patel, Manish;
    • Fakhri, Bita;
    • Xuan Tan;
    • Lewis, Katharine;
    • Flinn, Ian;
    • Lewis, Davud;
    • Le Gouill, Steven;
    • Palomba, Lia;
    • Woyach, Jennifer;
    • Pagel, John;
    • Lamanna, Nicole;
    • Cohen, Johnathon;
    • Barve, Minal;
    • Ghia, Paolo;
    • Eyre, Toby
    Publication type:
    Article
    4

    Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: updated results from the phase 1/2 BRUIN study.

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 33
    By:
    • Jurczak, Wojciech;
    • Mato, Anthony;
    • Pagel, John;
    • Coombs, Catherine C.;
    • Shah, Nirav N.;
    • Lamanna, Nicole;
    • Lech-Maranda, Ewa;
    • Eyre, Toby A.;
    • Munir, Talha;
    • Woyach, Jennifer A.;
    • Wierda, William G.;
    • Cheah, Chan Y.;
    • Cohen, Jonathon;
    • Roeker, Lindsey;
    • Patel, Manish R.;
    • Fakhri, Bita;
    • Barve, Minal A.;
    • Tam, Constantine S.;
    • Lewis, David;
    • Gerson, James N.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1226, doi. 10.4143/crt.2017.446
    By:
    • Sabatier, Renaud;
    • Diéras, Véronique;
    • Pivot, Xavier;
    • Brain, Etienne;
    • Roché, Henri;
    • Extra, Jean-Marc;
    • Monneur, Audrey;
    • Provansal, Magali;
    • Tarpin, Carole;
    • Bertucci, François;
    • Viens, Patrice;
    • Zemmour, Christophe;
    • Gonçalves, Anthony
    Publication type:
    Article
    12

    Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results.

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 2, p. 423, doi. 10.4143/crt.2016.191
    By:
    • Yeon Hee Park;
    • Tae Yong Kim;
    • Young-Hyuck Im;
    • Keun-Seok Lee;
    • In Hae Park;
    • Joohyuk Sohn;
    • Soo-Hyeon Lee;
    • Seock-Ah Im;
    • Jee Hyun Kim;
    • Se Hyun Kim;
    • Soo Jung Lee;
    • Su-Jin Koh;
    • Ki Hyeong Lee;
    • Yoon Ji Choi;
    • Eun Kyung Cho;
    • Suee Lee;
    • Seok Yun Kang;
    • Jae Hong Seo;
    • Sung-Bae Kim;
    • Kyung Hae Jung
    Publication type:
    Article
    13

    Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

    Published in:
    2023
    By:
    • Coombes, R. C.;
    • Howell, Sacha;
    • Lord, Simon R.;
    • Kenny, Laura;
    • Mansi, Janine;
    • Mitri, Zahi;
    • Palmieri, Carlo;
    • Chap, Linnea I.;
    • Richards, Paul;
    • Gradishar, William;
    • Sardesai, Sagar;
    • Melear, Jason;
    • O'Shaughnessy, Joyce;
    • Ward, Patrick;
    • Chalasani, Pavani;
    • Arkenau, Tobias;
    • Baird, Richard D.;
    • Jeselsohn, Rinath;
    • Ali, Simak;
    • Clack, Glen
    Publication type:
    Correction Notice
    14
    15

    Assessment of the Mechanisms of Action of Eribulin in Patients with Advanced Liposarcoma Through the Evaluation of Radiological, Functional, and Tissue Responses: A Prospective Monocentric Study (Malibu Study).

    Published in:
    Cancers, 2025, v. 17, n. 6, p. 976, doi. 10.3390/cancers17060976
    By:
    • Grimaudo, Maria Susanna;
    • D'Orazio, Federico;
    • Renne, Salvatore Lorenzo;
    • D'Incalci, Maurizio;
    • Maki, Robert G.;
    • Colombo, Piergiuseppe;
    • Balzarini, Luca;
    • Laffi, Alice;
    • Santoro, Armando;
    • Bertuzzi, Alexia Francesca
    Publication type:
    Article
    16

    Eribulin-Induced Peripheral Neuropathy in Locally Advanced or Metastatic Breast Cancer: Final Analysis of the Prospective Cohort IRENE Study.

    Published in:
    Cancers, 2025, v. 17, n. 3, p. 457, doi. 10.3390/cancers17030457
    By:
    • Schmidt, Marcus;
    • Hesse, Tobias;
    • Hoffmann, Oliver;
    • Heinrich, Bernhard J.;
    • Park-Simon, Tjoung-Won;
    • Grischke, Eva-Maria;
    • Weide, Rudolf;
    • Müller Huesmann, Harald;
    • Lüdtke-Heckenkamp, Kerstin;
    • Fischer, Dorothea;
    • Zemlin, Cosima;
    • Kögel, Matthias;
    • Jia, Yan;
    • Schmitz, Helga;
    • Engelbrecht, Christian;
    • Jackisch, Christian
    Publication type:
    Article
    17
    18

    Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors.

    Published in:
    Cancers, 2023, v. 15, n. 24, p. 5854, doi. 10.3390/cancers15245854
    By:
    • Janik, Anna Maria;
    • Terlecka, Anna;
    • Spałek, Mateusz J.;
    • Boye, Kjetil;
    • Szostakowski, Bartłomiej;
    • Chmiel, Paulina;
    • Szumera-Ciećkiewicz, Anna;
    • Bobak, Klaudia;
    • Świtaj, Tomasz;
    • Rutkowski, Piotr;
    • Czarnecka, Anna M.
    Publication type:
    Article
    19
    20
    21
    22

    Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.

    Published in:
    Cancers, 2022, v. 14, n. 23, p. 5880, doi. 10.3390/cancers14235880
    By:
    • López González, Ana;
    • Del Barco Berrón, Sonia;
    • Grau, Isabel;
    • Galan, Maria;
    • Castelo Fernández, Beatriz;
    • Cortés, Alfonso;
    • Sánchez Rovira, Pedro;
    • Martinez-Bueno, Alejandro;
    • Gonzalez, Xavier;
    • García, Almudena;
    • Gener, Petra;
    • Mina, Leonardo;
    • Alcalá-López, Daniel;
    • Sampayo, Miguel;
    • Cortés, Javier;
    • Pérez-Garcia, José Manuel;
    • Llombart-Cussac, Antonio;
    • López-Miranda, Elena
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    CD46 targeted <sup>212</sup>Pb alpha particle radioimmunotherapy for prostate cancer treatment.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02636-x
    By:
    • Li, Jun;
    • Huang, Tao;
    • Hua, Jun;
    • Wang, Qiong;
    • Su, Yang;
    • Chen, Ping;
    • Bidlingmaier, Scott;
    • Li, Allan;
    • Xie, Zhongqiu;
    • Bidkar, Anil P.;
    • Shen, Sui;
    • Shi, Weibin;
    • Seo, Youngho;
    • Flavell, Robert R.;
    • Gioeli, Daniel;
    • Dreicer, Robert;
    • Li, Hui;
    • Liu, Bin;
    • He, Jiang
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77898-y
    By:
    • Tsuchihashi, Kenji;
    • Kusaba, Hitoshi;
    • Yoshihiro, Tomoyasu;
    • Fujiwara, Toshifumi;
    • Setsu, Nokitaka;
    • Endo, Makoto;
    • Matsumoto, Yoshihiro;
    • Imajima, Takashi;
    • Shinohara, Yudai;
    • Ito, Mamoru;
    • Yamaga, Satoru;
    • Tanoue, Kenro;
    • Arimizu, Kohei;
    • Ohmura, Hirofumi;
    • Hanamura, Fumiyasu;
    • Yamaguchi, Kyoko;
    • Isobe, Taichi;
    • Ariyama, Hiroshi;
    • Nakashima, Yasuharu;
    • Akashi, Koichi
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50

    Correction.

    Published in:
    2021
    Publication type:
    Correction Notice